Literature DB >> 7711113

Retrodifferentiation and cell death.

R Hass1.   

Abstract

The reversibility of a differentiation program termed dedifferentiation, redifferentiation, or retrodifferentiation opens a spectrum of new possibilities for cellular development. During differentiation and retrodifferentiation, the expression of gene products associated with a differentiated phenotype and cell cycle regulation demonstrate inverse patterns. This effect requires a coordinated network that simultaneously controls cell growth and differentiation. In particular, crosstalk between induction of differentiation and G0/G1 cell cycle exit can be initiated and sustained by activated serine/threonine kinases and tyrosine kinases. Phosphorylation signals are relayed to certain genes or transcription factors such as Fos/Jun, EGR-1, NF-kappa B, MyoD, or the Myc/Max gene family. However, the precise regulation of these transcription factors to confer signals to differentiation-associated and cell cycle-regulatory genes remains unclear. Cell cycle exit into a transient G0'-arrest cycle or a terminal G0 phase is determined by a network of phosphorylation signals involving the retinoblastoma protein and a variety of factors such as the E2F family, cyclins, and cyclin-dependent kinases. In this context, a variety of differentiation-induced cell lines, including monocytic, neuronal, or muscle cells, can progress through the G0'-arrest cycle, whereby a certain population retains the capacity to retrodifferentiate and reenter the cell cycle. In contrast, the rest of the differentiated population enters the irreversible G0 phase (terminal commitment) that finally results in programmed cell death. The expression of growth arrest-specific (gas and gadd) genes is associated with the G0'-arrest cycle, and other factors, including c-myc, p53, mdm2, and bcl2/bclx, contribute to the regulation of the cell death program. Although the precise signaling cascade determining retrodifferentiation or cell death remains unclear, a coordinated inter- and intracellular regulation could establish a certain biological balance between these exclusive pathways. Consequently, a retrodifferentiation process may provide a potential for cell type conversion or transdifferentiation, whereby retrodifferentiated cells can be induced to develop via a different pathway according to tissue-specific requirements.

Entities:  

Mesh:

Year:  1994        PMID: 7711113     DOI: 10.1615/critrevoncog.v5.i4.20

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  11 in total

1.  Expression of progenitor cell markers during expansion of sorted human pancreatic beta cells.

Authors:  Thomas Bouckenooghe; Brigitte Vandewalle; Ericka Moerman; Pierre-Marie Danzé; Bruno Lukowiak; Ghaffar Muharram; Julie Kerr-Conte; Valery Gmyr; Bernard Laine; François Pattou
Journal:  Gene Expr       Date:  2005

2.  Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation.

Authors:  Florian Grabellus; Sien-Yi Sheu; Boris Schmidt; Michael Flasshove; Cornelius Kuhnen; Steffen Ruchholtz; Georg Taeger; Kurt Werner Schmid
Journal:  Virchows Arch       Date:  2005-10-14       Impact factor: 4.064

Review 3.  Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.

Authors:  Tadashi Uwagawa; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2015-02-12       Impact factor: 2.549

Review 4.  Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas.

Authors:  Diana Marcela Muñoz; Abhijit Guha
Journal:  Oncotarget       Date:  2011-08

Review 5.  Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

Review 6.  The Intimate Relationship Among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

Review 7.  The multi-differentiation potential of peripheral blood mononuclear cells.

Authors:  Min Zhang; Bing Huang
Journal:  Stem Cell Res Ther       Date:  2012-11-30       Impact factor: 6.832

8.  TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass; Hendrik Ungefroren
Journal:  Int J Mol Sci       Date:  2017-07-20       Impact factor: 5.923

Review 9.  Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.